ARTICLE | Company News
Agendia sales and marketing update
September 8, 2008 7:00 AM UTC
Agendia launched its TargetPrint breast cancer prognostic test in the U.S. to identify patients likely to benefit from hormone treatments after surgery. The test measures gene expression levels of th...